Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Williams

Showing results (41-50 of 394) with videos related to

Pageof 40
Sort By:
The New Zealand Medical Journal|January 29, 2003
Inflammation, atherosclerosis and predicting cardiovascular riskMichael Williams, Ralph Stewart
BMJ (Clinical Research Ed.)|February 23, 2017
Gavin Beddie TaylorPierre Fouin, Michael Williams
Drug Discovery Today|January 25, 2012
Translational semantics and infrastructure: another search for the emperor's new clothes?Kevin Mullane, Michael Williams
Journal of Neural Engineering|May 5, 2011
Computationally efficient bioelectric field modeling and effects of frequency-dependent tissue capacitanceBrian Tracey, Michael Williams
Biochemical Pharmacology|August 20, 2013
Defining and characterizing drug/compound functionTerry Kenakin, Michael Williams
Biochemical Pharmacology|August 5, 2015
Unknown unknowns in biomedical research: does an inability to deal with ambiguity contribute to issues of irreproducibility?Kevin Mullane, Michael Williams
Biochemical Pharmacology|April 6, 2020
Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?Kevin Mullane, Michael Williams
BMJ Open Ophthalmology|September 5, 2022
Long-term outcomes for patients treated for macular oedema secondary to retinal vein occlusion: a systematic reviewAlexandra Hunter, Michael Williams
Current Opinion in Pharmacology|December 15, 2019
EditorialMichael Williams, David Trist
Biochemical Pharmacology|October 2, 2018
Alzheimer's disease (AD) therapeutics - 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causalityKevin Mullane, Michael Williams
Pageof 40

Showing results (41-50 of 394) with videos related to

Sort By:
Pageof 40
The New Zealand Medical Journal|January 29, 2003
Inflammation, atherosclerosis and predicting cardiovascular riskMichael Williams, Ralph Stewart
BMJ (Clinical Research Ed.)|February 23, 2017
Gavin Beddie TaylorPierre Fouin, Michael Williams
Drug Discovery Today|January 25, 2012
Translational semantics and infrastructure: another search for the emperor's new clothes?Kevin Mullane, Michael Williams
Journal of Neural Engineering|May 5, 2011
Computationally efficient bioelectric field modeling and effects of frequency-dependent tissue capacitanceBrian Tracey, Michael Williams
Biochemical Pharmacology|August 20, 2013
Defining and characterizing drug/compound functionTerry Kenakin, Michael Williams
Biochemical Pharmacology|August 5, 2015
Unknown unknowns in biomedical research: does an inability to deal with ambiguity contribute to issues of irreproducibility?Kevin Mullane, Michael Williams
Biochemical Pharmacology|April 6, 2020
Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?Kevin Mullane, Michael Williams
BMJ Open Ophthalmology|September 5, 2022
Long-term outcomes for patients treated for macular oedema secondary to retinal vein occlusion: a systematic reviewAlexandra Hunter, Michael Williams
Current Opinion in Pharmacology|December 15, 2019
EditorialMichael Williams, David Trist
Biochemical Pharmacology|October 2, 2018
Alzheimer's disease (AD) therapeutics - 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causalityKevin Mullane, Michael Williams
Pageof 40